About Pancreatic Cancer
The number of people diagnosed with pancreatic cancer in 2017 was 53,670. The average life span after diagnosis is only six months and 71% of those diagnosed will not survive more than one year. The five year survival rate is less than 9%. Pancreatic cancer, currently the 3rd leading cause of cancer death, is expected to become the 2nd by 2020. In spite of the number of people affected by the staggering mortality rate of this disease which is higher than all other major cancers, research funding for pancreatic cancer is shockingly inadequate; having remained largely unchanged for the past 40 years.
Our mission is to both raise money for pancreatic cancer research and treatment as well as make people aware of the funding needs. Currently, Pancreatic Cancer receives:
- Less than 2% of the National Cancer Institute’s (NCI) research budget
- Slightly more than $100 million from the federal government, while AIDS, affecting 40,000 new US residents each year, is appropriated more than $3 billion
Most of our funding is directed towards research, with all our research funding to-date going to Sidney Kimmel Cancer Center at Jefferson University; an NCI-designated facility. This is the leading pancreatic cancer research and treatment center in our region and where Amy received her treatment. Other funding has been directed to patient programs and patient support at both Jefferson and St. Luke’s Hospital. St. Luke’s Quakertown Campus, located in our direct community, will distribute funding to support pancreatic cancer patients in need.
To donate via check
Make check payable to: “Pan-Cure”
PO Box 722
Quakertown, PA 18951
J’s Run – 5K Run in Bethlehem